Citations 11
Phase 2 trial of PRM-151, an antifibrotic agent, in patients with myelofibrosis: Stage 1 results.
Foltz, Lynda, Ritchie, Ellen K. , Silver, Richard T. , Hong, Wan‐Jen , Kremyanskaya, Marina , Trehu, Elizabeth, Verstovšek, Srđan , Mesa, Ruben A. , Gupta, Vikas , Mascarenhas, John , Hoffman, Ronald , Kantarjian, Hagop M. , Gotlib, Jason
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 7114-7114
